Workforce Development & LeadershipCatalio-Backed Rhapsogen Appoints Renato Skerlj as CEOBusiness WireJanuary 7, 2026January 8, 2026 by Business WireJanuary 7, 2026January 8, 2026061 Dr. Skerlj brings significant drug development experience to lead biotech startup in its mission to develop next-gen autoimmune treatments Rhapsogen, an immunology company redefining the...